Current Shortage Status
Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion
Low NHSBSA SSPBaxter Healthcare Corporation have informed the MHRA that the Patient Information Leaflet (PIL) packed in specified batches does not contain up to date information relating to the duration of contrace
What to Do If You're Affected
- Contact your pharmacy as soon as possible — don't wait until you run out
- Ask your pharmacist if a Serious Shortage Protocol (SSP) is active
- Speak to your GP about prescribing an alternative
- Try other local pharmacies who may have different stock
- Sign up for MediWatch alerts to track this shortage
Frequently Asked Questions
Is Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone in shortage in the UK in 2026?
Yes — as of 27 March 2026, there is 1 active shortage notification for Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone in the UK, issued by DHSC or NHSBSA. Sign up for MediWatch alerts to be notified of any changes.
What is Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone used for?
Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone is commonly prescribed in the UK for various medical conditions. It is dispensed through NHS pharmacies across the country.
What should I do if I can't get Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone from my pharmacy?
First, ask your pharmacist if a Serious Shortage Protocol (SSP) is active — this may allow them to dispense an alternative without a new prescription. If not, contact your GP who can prescribe a suitable alternative. Try other local pharmacies as stock levels vary by location.
Page last updated: 27 March 2026. Data checked daily.